Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports

Intellia Therapeutics Inc. (NTLA : NSD)

Sector: Healthcare

Close
(12-12-2025)
$9.02
Change
-$0.53 (-5.55%)
Volume 3,400,252
Open $9.61
Day Range $9.02 - $9.68
52 Week Low $5.90
52 Week High $28.25
Annual Yield -
Annual Dividend -
Last Dividend -
Industry Sector Healthcare
Quoted Market Value $1,044,785,933
Shares Outstanding 115,829,926
Book Value per Share $1.40
Earnings per Share -$4.27
Period
Loading...
Loading...

Legend

Intellia Therapeutics Inc.

Compare Options


Pricing History (Last 30 Days)

Pricing History
Date Close Change
December 12, 2025 9.02
-$0.53 (-5.55%)
December 11, 2025 9.55
$0.18 (1.92%)
December 10, 2025 9.37
$0.07 (0.75%)
December 09, 2025 9.30
-$0.14 (-1.48%)
December 08, 2025 9.44
-$0.17 (-1.77%)
December 05, 2025 9.61
-$0.13 (-1.33%)
December 04, 2025 9.74
$0.68 (7.51%)
December 03, 2025 9.06
$0.96 (11.85%)
December 02, 2025 8.10
-$0.32 (-3.80%)
December 01, 2025 8.42
-$0.57 (-6.34%)
November 28, 2025 8.99
$0.47 (5.52%)
November 27, 2025 8.52
$0.00 (0.00%)
November 26, 2025 8.52
-$0.03 (-0.35%)
November 25, 2025 8.55
$0.20 (2.40%)
November 24, 2025 8.35
$0.14 (1.71%)
November 21, 2025 8.21
$0.17 (2.11%)
November 20, 2025 8.04
-$0.20 (-2.43%)
November 19, 2025 8.24
-$0.23 (-2.72%)
November 18, 2025 8.47
-$0.01 (-0.12%)
November 17, 2025 8.48
-$0.22 (-2.53%)
November 14, 2025 8.70
$0.03 (0.35%)
November 13, 2025 8.67
-$0.82 (-8.64%)
November 12, 2025 9.49
-$0.69 (-6.78%)
November 11, 2025 10.18
$0.45 (4.62%)
November 10, 2025 9.73
$0.21 (2.21%)
November 07, 2025 9.52
-$2.80 (-22.73%)
November 06, 2025 12.32
-$1.25 (-9.21%)
November 05, 2025 13.57
$1.37 (11.23%)
November 04, 2025 12.20
-$0.87 (-6.66%)
November 03, 2025 13.07
$0.45 (3.57%)

Funds holding this stock

Try Fund Library Premium

For Free with a 30 day trial!

Gain access to

  • Unlimited Watchlists
  • Advanced Search Filtering
  • Fund Comparisons
  • Portfolio Scenarios
  • Customizable PDF Reports